Immunic Therapeutics advances MS Drug , Phase 2 CALLIPER trial readout in April

By Proactive Investors / March 11, 2025 / www.youtube.com / Article Link


Immunic Therapeutics Chief Scientific Officer Dr. Hella Kohlhof joined Steve Darling from Proactive to discuss the company's ...

Recent News

Gold stocks down as markets continue to new highs

July 21, 2025 / www.canadianminingreport.com

TSXV Top 20 Gold market cap shifts away from exploration

July 21, 2025 / www.canadianminingreport.com

Many new players enter TSXV gold Top 25 by market cap

July 14, 2025 / www.canadianminingreport.com

Gold stocks mixed on moderate metal gain, flat equities

July 14, 2025 / www.canadianminingreport.com

Gold stocks lead the large cap miners by far over H1/25

July 07, 2025 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok